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ABSTRACT 
     Conformations of two pairs of dehydropeptides with the opposite configuration of the ∆Phe 
residue, Boc-Gly-∆ZPhe-Gly-Phe-OMe (Z-OMe), Boc-Gly-∆EPhe-Gly-Phe-OMe (E-OMe), Boc-
Gly-∆ZPhe-Gly-Phe-p-NA (Z-p-NA), and Boc-Gly-∆EPhe-Gly-Phe-p-NA (E-p-NA) were 
compared on the basis of CD and NMR studies in MeOH, TFE, MeCN, chloroform, and DMSO. 
The CD results were used as the additional input data for the NMR-based determination of the 
detailed solution conformations of the peptides. It was found that E-OMe is unordered and Z-OMe, 
Z-p-NA, and E-p-NA adopt the β-turn conformation. There are two overlapping β-turns in each of 
those peptides: type II and type III’ in Z-OMe and Z-p-NA, and two type III in E-p-NA. The 
ordered structure-inducing properties of ∆ZPhe and ∆EPhe in the peptides studied depend on the C-
terminal blocking group. In methyl esters the ∆ZPhe residue is a strong inducer of ordered 
conformations whereas the ∆EPhe one has no such properties. In p-nitroanilides, both isomers of 
∆Phe cause the peptides to adopt ordered structures to a similar extent. 
Keywords: dehydropeptides; dehydrophenylalanine configuration; circular dichroism; nuclear 
magnetic resonance; dehydropeptide conformation 
 
INTRODUCTION 
     α,β-Dehydroamino acid residues (α,β-unsaturated or ∆-amino acid residues) contain a double 
bond between the Cα and Cβ atoms. This structural feature endows them with the ability to limit the 
conformational freedom of peptides. These ∆-amino acids, which have different substituents on the 
Cβ carbon atom, can exist in two forms - as isomers Z, with the older substituent in position cis to 
the nitrogen atom, and isomers E, with this substituent trans to nitrogen. Isomers Z are more 
thermodynamically stabble than their E counterparts and hence easier to obtain. It has been shown 
recently, though, that poly-∆Abu exists in alternate ∆ZAbu and ∆EAbu form rather than the all Z- 
form.1 A great majority of papers published so far on dehydropeptides deal with ∆-amino acid 
residues of the Z configuration. The most studied dehydroamino acid residue has been 
dehydrophenylalanine. It has been found that in the solid state a ∆Phe residue of the Z configuration 
induces β-turns in short sequences2-6 and a 310-helix in longer ones or peptides with more than one 
dehydro residue.4,7-19 Similar conformational properties of ∆ZPhe have been observed in solution by 
NMR8,11,19-34 and CD,18,19,27-44 though other, unusual structures have also been reported.45 The 
∆
ZPhe residues have also a potential to introduce long-range interactions in peptides46,47 or to be a β 
structure breaker.48 
     Much less is known about the conformational preferences of a ∆Phe residue of the E 
configuration. Few crystal structures of ∆EPhe-containing peptides show that this residue occupies 
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the i+1 position in type II or II’ β-turn.17,49,50 NMR and CD studies on ∆EPhe-containing peptides51-
54
 revealed that this residue favours formation of the folded conformations of the β-turn type. 
     So far, in the literature there has been no paper with a direct comparison of the conformational 
properties of dehydropeptides containing a single ∆Phe residue and differing only by its 
configuration. Therefore, we wanted to check how the dehydroamino acid residue configuration 
influences a dehydropeptide conformation. In this connection we investigated the conformations of 
two following peptides:  
Boc-Gly-∆ZPhe-Gly-Phe-OMe (Z-OMe) 
Boc-Gly-∆EPhe-Gly-Phe-OMe (E-OMe) 
     The absorption and CD spectra of Z-OMe in MeOH have been presented in ref. 17 but the 
peptide has been used there as a model compound and its conformation has not been discussed at 
all. We investigated the conformations of the two methyl esters by CD in MeOH, TFE, MeCN, and 
chloroform, and NMR in CDCl3 and DMSO-d6.  
     So far, the detailed solution conformations of dehydropeptides have been derived from the NMR 
alone. This approach has some disadvantages because a peptide in solution is a dynamic system. In 
the cases of small and dynamic systems when there is a small number of ROE contacts per residue 
and often ambiguous 3JHH couplings information, the NMR is not capable of sufficient solution 
structure determination. In such a case the CD can give additional information on the peptide 
conformation, e.g. whether a peptide is folded or unordered or what type of a β-turn dominates in its 
conformational equilibrium. In this paper we applied an integrated approach which consists in 
combining the NMR and CD results to obtain the detailed solution conformations of the peptides 
studied. We used successfully such an approach in our conformational studies on the decapeptide 
fragment of ubiquitin.55
  
     Basing on CD and NMR studies we present the detailed solution conformations of Z-OMe and 
E-OMe. The conformational properties of the methyl esters were compared with those of two very 
similar peptides: 
Boc-Gly-∆ZPhe-Gly-Phe-p-NA  (Z-p-NA) 
Boc-Gly-∆EPhe-Gly-Phe-p-NA  (E-p-NA) 
differing from the first pair only by the C-terminal blocking group. The X-ray1 and CD studies17 
have shown that Z-p-NA adopts a type II β-turn conformation at the ∆ZPhe2 and Gly3 residues, in 
the solid state and solution. Both p-nitroanilides have also been studied by NMR18,51 but these 
investigations have not allowed to present the detailed solution conformations of the peptides. In 
this connection we carried out anew the NMR studies on Z-p-NA and E-p-NA in DMSO. The latter 
peptide was also studied by CD in MeOH, MeCN, TFE, and DMSO. The CD spectrum of Z-p-NA 
in DMSO was measured as well. The CD and NMR studies on Z-p-NA and E-p-NA yielded the 
detailed solution structures of both peptides. The results presented in this paper may have 
implications for the de novo design of peptides with specific conformations in solution. 
 
EXPERIMENTAL PROCEDURES 
Synthesis of peptides 
     The syntheses of Z-OMe, Z-p-NA, and E-p-NA have been described in references 18, 56, and 
51, respectively. 
     Boc-Gly-∆EPhe-Gly-Phe-OMe (E-OMe). Boc-Gly-∆EPhe-Gly-OH was obtained from Boc-
Gly-∆EPhe-Gly-OMe51 by a standard basic hydrolysis with a 30% excess of 1 M NaOH in MeOH. 
Yield 98%; mp 127-130°C; elemental analysis calcd (%) for C18H23N3O6 (377.39): C 57.29, H 6.14, 
N 11.40; found: C 57.59, H 6.00, N 11.11. 
     TEA (0.143 mL, 1.05 mmol) was added to the solution of Boc-Gly-∆EPhe-Gly-OH (0.189 g, 0.5 
mmol) and HCl·Phe-OMe (0.108 g, 0.5 mmol) in MeCN (3 mL). After 5 min TBTU (0.168 g, 0.55 
mmol) was added and the solution was stirred for 10 h at room temperature. Then MeCN was 
evaporated and the resulting oil was dissolved in ethyl acetate (50 mL). The solution was washed 
with 1 M HCl (3 × 3 mL), saturated solution of KHCO3 (3 × 3 mL), and brine (3 mL). Then it was 
dried with MgSO4 and ethyl acetate was evaporated in vacuo. Crude E-OMe was crystallized from 
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CHCl3-ethyl acetate (9:1, v/v)/hexane. Yield 0.247 g (92%); mp 100-102°C; elemental analysis 
calcd (%) for C28H34N4O7 (538.58): C 62.44, H 6.36, N 10.40; found: C 62.56, H 6.20, N 10.21. 1H 
NMR (500 MHz, CDCl3) δ (ppm): 1.43 (9H, s, 3 × CH3 Boc); 3.09 (2H, d-d, CβH2 Phe4); 3.66 (3H, 
s, COOCH3); 3.71 (1H, d-d, CαH1 Gly3); 3.85 (1H, d-d, CαH2 Gly3); 3.90 (2H, broad s, CαH2 Gly1); 
4.75 (1H, q, CαH Phe4); 5.37 (1H, t, NH Gly1); 6.39 (1H, broad t, NH Gly3); 7,11 (1H, d, NH Phe4); 
7.19-7.31 (11H, m, aromatic of Phe4 and ∆EPhe2; CβH ∆EPhe2); 8.69 (1H, broad s, NH ∆EPhe2). 
Absorption Spectra 
     Absorption spectra were measured with a Cary 500 Scan UV-Vis-NIR spectrophotometer in 
MeOH, at room temperature. Pathlength of 1 mm was used. Concentration of the solutions was 5 × 
10-4 M. 
Circular Dichroism Spectroscopy 
     CD spectra were recorded on a Jasco J-600 spectropolarimeter, at room temperature. Spectra 
were measured in MeOH, TFE, MeCN, chloroform, and DMSO. Pathlength of 1 mm was used. 
Concentrations of the solutions were in the range of 0.17-0.21 mg/mL (2.6-3.9 × 10-4 M). Each 
spectrum represents the average of at least four scans. The data are presented as molar ellipticity 
[θ]. 
NMR Spectroscopy 
     NMR spectra of Z-OMe and E-OMe were recorded at 11.7 T on a Varian Unity+ 500 
spectrometer at 25°C, in CDCl3 and DMSO-d6. NMR spectra of Z-p-NA and E-p-NA were 
measured at 11.7 T with a Bruker Avance 500 spectrometer at 25°C, in DMSO-d6. Two-
dimensional homonuclear NMR spectra were processed with NMRPipe57 and analyzed with 
SPARKY57 programs. Complete assignments of the 1H and 13C resonances for all the peptides were 
done by application of a standard procedure58 based on inspection of the 2D homonuclear TOCSY 
(with mixing times 10 and 90 ms) and ROESY (with mixing times 200 and 500 ms) experiments. 
Accuracies of the estimated proton chemical shifts and 3JHH coupling constants are 0.02 ppm and 
0.4 Hz, respectively. The temperature coefficients of amide protons of methyl esters and p-
nitroanilides were measured in CDCl3 and DMSO-d6, respectively, at the temperature range from 
291 K to 318 K, with a temperature interval of 3 K. Chemical shifts are given as δ in relation to 
SiMe4 as internal standard. In all cases 15 mM peptide solutions were used. Calculations of lowest-
energy structures, carried out for peptides which exhibited ordered conformations in solution 
according to CD, were performed with an X-PLOR NIH 2.21 program package.59 Figures 
presenting the calculated structures were prepared with a MolMol software.60 Supplementary data 
are available from the authors upon request.  
 
RESULTS  
Absorption spectra 
     The absorption features of Z-OMe, E-OMe, Z-p-NA, and E-p-NA in the near-UV region are 
presented in Table I. The spectra of Z-OMe and E-OMe show a large, broad band at 280 nm, 
similar to those observed for other mono-unsaturated ∆ZPhe peptides.35,36,42 It is an intramolecular 
charge-transfer band originating from the cinnamic chromophore C6H5C=C–C=O of the ∆Phe 
residue, from the highest occupied orbital of the electron-donating styryl group to the vacant orbital 
of the electron-accepting carbonyl group.35,61 In the case of Z-p-NA and E-p-NA, the ∆Phe residue 
band at 280 nm is overlapped by a charge-transfer band of the p-NA group at 315 nm.18 The spectra 
of Z-p-NA and E-p-NA are very similar. They show a band at 286 and 289 nm, respectively, with a 
shoulder at about 325 nm which is quite distinct for Z-p-NA and poorly visible for E-p-NA. The 
spectra of both pairs of peptides show that the ∆Phe residue configuration has only a slight 
influence on their shape.  
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CD Studies 
     The CD spectra of Z-OMe and E-OMe in MeOH, TFE, MeCN, and chloroform are presented in 
Fig. 1. The spectra of Z-OMe in MeOH and chloroform are very similar. They show a large 
negative band at 280 nm, a little more intensive in the latter solvent. In TFE and MeCN this band, at 
278 and 273 nm, respectively, is about twice smaller than in chloroform and MeOH. The CD 
spectra of E-OMe are much less differentiated. They show a very small, broad, positive band at 
270-279 nm, the most intensive in MeOH and the smallest in MeCN.  
     The CD spectra of Z-p-NA and E-p-NA in MeOH, TFE, MeCN, and DMSO are shown in Fig. 
2. They look to a some extent like mirror images. The spectra of Z-p-NA in MeOH and TFE are 
very similar. There is a large, positive p-NA band at 311 and 308 nm, and a large, negative ∆ZPhe 
band at 275 and 273 nm, in those spectra. The spectrum of Z-p-NA in MeCN differs from those in 
MeOH and TFE by the bands intensity. In MeCN, the p-NA band at 308 nm is much stronger, and 
the ∆ZPhe residue band at 273 nm much weaker, than in MeOH and TFE. There is a large 
difference between the CD spectra of Z-p-NA in DMSO and other solvents. In DMSO, the positive 
p-NA band at 318 nm and the negative ∆ZPhe band at 280 nm are distinctly smaller than in other 
solvents, especially the latter. The spectra of E-p-NA are less differentiated than those of Z-p-NA. 
In MeOH, TFE, and MeCN, there is a large negative p-NA band at 309-314 nm and a large positive 
∆
EPhe band at 274-278 nm. The spectrum in DMSO is similar in its shape to the spectra in other 
solvents but it is shifted somewhat to longer wavelengths, with a negative and a positive band at 
319 and 284 nm, respectively. 
NMR Studies 
     To detect intramolecular hydrogen bonds in the peptides investigated the temperature 
dependence of their amide protons was measured. It is well known that amide proton chemical 
shifts are sensitive to temperature changes. If a proton forms a hydrogen bond, then its chemical 
shift shows a very small dependence on the temperature. The parameter which indicates the 
presence or absence of hydrogen bonds is a dδ/dT (ppm K-1) coefficient. It has been established that 
amide protons in protein systems, which are characterized by the temperature coefficient value 
lower than 0.0046 ppm K-1, are involved in hydrogen bonds.62 This value is often used for checking 
if any amide protons are involved in hydrogen bonds. The temperature coefficients of amide 
protons in the studied peptides are presented in Table II. They show that there are two hydrogen 
bonds in Z-OMe, Z-p-NA, and E-p-NA. They are formed by amide protons of Gly3 and Phe4 in Z-
OMe and Z-p-NA, and of Phe4 and p-NA in E-p-NA. The values of temperature coefficients of 
Gly3 and Phe4 amide protons in Z-OMe are larger than the 0.0046 limit value but other results 
presented below confirm that the two protons form hydrogen bonds. A low value of the Phe4 amide 
proton temperature coefficient in E-OMe, lower than for Gly3 and Phe4 amide protons in Z-OMe, 
suggests that this proton also forms an intramolecular hydrogen bond. Still, other results obtained 
for that peptide, described below, are in contradiction with such a possibility. Another way of 
checking for the presence of intramolecular hydrogen bonds in peptides is determination of the 
dependence of the amide protons chemical shifts on the solvent polarity. In the case of protons 
involved in hydrogen bonds that dependence is distinctly smaller than for non-hydrogen bonded 
ones. The results obtained for the methyl esters, measured in CDCl3 and DMSO-d6, are shown in 
Table III. They confirm the presence of two hydrogen bonds in Z-OMe, formed by amide protons 
of Gly3 and Phe4, and indicate the absence of a hydrogen bond in E-OMe. Such studies were not 
performed for the p-nitroanilides due to their poor solubility in chloroform.  
     Important information on the conformational properties of Z-OMe, E-OMe, Z-p-NA, and E-p-
NA were obtained from the ROESY spectra. On their basis interatomic contacts in the peptides 
studied could be detected. Trivial, intraresidue contacts are present in each investigated peptide. 
Non-trivial contacts were observed only for Z-OMe, Z-p-NA, and E-p-NA. They are presented in 
Table IV. Such contacts are absent in E-OMe, confirming the lack of intramolecular hydrogen 
bonds in that peptide. These contacts were used as the input data for calculations of the lowest-
energy conformers of Z-OMe, Z-p-NA, and E-p-NA. Besides them, the calculations were based 
only on the unambiguous results obtained at the same time by the NMR and CD. E.g., if the NMR 
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spectrum of a peptide indicated that two amide protons are involved in intramolecular hydrogen 
bonds, suggesting the presence of two β-turns, and the CD spectrum showed that there are two β-
turns, one of a given type, at specific residues and stabilized by a hydrogen bond formed by one of 
those  amide protons detected by NMR as hydrogen-bonded, and the other whose type and location 
could not be determined exactly by CD, then only this first β-turn with its hydrogen bond were used 
in the calculations. Such an approach was applied for Z-OMe and Z-p-NA. In the case of E-p-NA, 
the CD results are not unambiguous. The CD spectra show the presence of two β-turns whose 
position could be determined only by the hydrogen bonds detected by the NMR (Table II). These 
turns are located at the ∆EPhe2-Gly3 and Gly3-Phe4 residues. They can be either of type II' or III. It 
gives four possibilities: II'/II', II'/III, III/II', and III/III. It was found that independently of which of 
those combinations was chosen, the calculations yielded very similar results. The results presented 
for E-p-NA (Table V) were obtained with the two hydrogen bonds, Phe4 NH···Gly1 CO and p-NA 
NH··· ∆EPhe2 CO, and the β-turns at the ∆EPhe2-Gly3 and Gly3-Phe4 residues, assumed to be of type 
II’ and III, respectively, as the input data. In the case of calculations based on combined NMR and 
CD results it was important to have the results from the both methods which could be directly 
compared. Such a situation took place in the case of Z-OMe and E-OMe whose NMR spectra were 
measured in chloroform which was also one of the solvents used for CD studies. Due to a very poor 
solubility of Z-p-NA and E-p-NA in chloroform, the NMR spectra of those peptides were measured 
in DMSO. Therefore, the CD spectra of Z-p-NA and E-p-NA were measured in DMSO as well. For 
E-p-NA, there is a large similarity between the CD spectra measured in DMSO and other solvents. 
However, the CD spectra of Z-p-NA in DMSO and other solvents differ very much from each other 
(Fig. 2). The CD spectrum of Z-p-NA in DMSO indicates that its conformation, contrary to that in 
MeOH, TFE, and MeCN and to the NMR results, is unordered to a large extent. Still, it is rather not 
the case here. So for that peptide the NMR results combined with the CD ones obtained not for 
DMSO but for MeOH, TFE, and MeCN, were used for the conformational calculations. The 
conformation of Z-p-NA in DMSO and the way the calculations were performed for that peptide 
will be discussed in the next section. The calculated lowest-energy conformers of Z-OMe, Z-p-NA, 
and E-p-NA are presented in Fig. 3a-c and the values of their dihedral angles are given in Table V. 
Fig. 3d-f also shows the ensembles of 50 lowest-energy structures of those peptides, chosen from 
the 500 calculated peptide conformers.  
 
DISCUSSION 
     The CD spectra of dehydropeptides in the far-UV region are difficult to analyze since there are 
overlapping contributions of the peptide, aromatic, and unsaturated chromophores. In this 
connection we limited our analysis of the spectra of four peptides studied to the near-UV region 
only. The peptides contain a ∆Phe residue which gives a large CD band in that region, at about 280 
nm, which is very sensitive to a dehydropeptide conformation.18,19,27-44 Thus, this residue is a very 
good conformational probe in the studies on dehydropeptides. Moreover, Z-p-NA and E-p-NA 
contain the p-NA group which has been also found to be a useful tool in the conformational studies 
on peptides.63-66   
     A large intensity of the negative ∆ZPhe CD bands of Z-OMe at 280 nm in MeOH, TFE, and 
MeCN (Fig. 1) shows that the peptide adopts a chiral, rigid structure of the same type in each 
solvent. This structure must involve the Phe4 residue because otherwise two enantiomeric forms of 
that conformation would be present in the conformational equilibrium of Z-OMe resulting in a very 
small intensity of the ∆ZPhe band. It has been found that a negative ∆ZPhe band at 280 nm is typical 
of dehydropeptides adopting a type II β-turn, with a ∆ZPhe residue at the i+2 position.42 The 
presence of such a band in the CD spectra of Z-OMe suggests that there is a type II β-turn in that 
peptide at the Gly1 and ∆ZPhe2 residues, stabilized by the intramolecular hydrogen bond between 
the amide proton of Gly3 and the carbonyl oxygen of the Boc group. But this conformation does not 
involve the Phe4 residue whereas the CD spectra show that this residue also must be a part of the 
ordered structure of Z-OMe. It suggests the presence of another β-turn in that peptide, at the ∆ZPhe2 
and Gly3 or Gly3 and Phe4 residues. Since the β-turn at Gly3 and Phe4 could not be stabilized by the 
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intramolecular 4→1 hydrogen bond due to the lack of a proton donor, the β-turn at ∆Phe2 and Gly3 
stabilized by the hydrogen bond between the amide proton of Phe4 and the carbonyl group of Gly1 
is much more probable. These conclusions were confirmed by the NMR studies on Z-OMe. They 
show the presence of two intramolecular hydrogen bonds, formed by the amide protons of Gly3 and 
Phe4 (Tables II and III). The dihedral angles of successive residues of Z-OMe (Table V) indicate 
that these hydrogen bonds stabilize two overlapping β-turns, of type II at Gly1 and ∆ZPhe2 and type 
III’ at ∆Phe2 and Gly3. Such a sequence of β-turns occurs very often in the case of Aib-containing 
peptides67,68 in which the N-terminal β-turn is followed by a left-handed 310 helical conformation, 
i.e. type III’ β-turns. It has been also observed for Boc-L-Val-∆ZPhe-∆ZPhe-∆ZPhe-L-Val-OMe.28 
The type III’ β-turn in Z-OMe corresponds very well with the CD spectra of that peptide. It has 
been found that ∆ZPhe-containing dehydropeptides in the type III β-turn conformation give a 
positive CD band at about 280 nm and a negative band at about 235 nm.42 It shows that 
dehydropeptides in the type III’ β-turn conformation should give a negative CD band at 280 nm and 
a positive one at 235 nm. This spectral pattern agrees with the CD spectra of Z-OMe in each 
solvent. Indeed no positive band at about 235 nm in those spectra is observed, which may be due to 
its overlap with a stronger positive band at shorter vawelengths, but there are positive ellipticities in 
that region, except the spectrum in MeCN. The intensities of the negative ∆ZPhe band at 280 nm 
suggest that the ordered conformation of Z-OMe is the most highly populated in chloroform and 
MeOH whereas in MeCN and TFE its population is decreased. The lowest-energy conformation of 
Z-OMe and a comparison of its 50 lowest-energy conformers are shown in Fig. 3 a and d, 
respectively. The ensemble of 50 lowest-energy structures indicates that Z-OMe is quite flexible in 
solution and it has a substantial conformational freedom. 
     A small intensity of the ∆EPhe CD bands of E-OMe (Fig. 1) at 270-280 nm in each solvent 
suggests that the peptide is unordered. The same result was obtained from the NMR studies which 
do not show any interatomic contacts that would suggest the ordered conformation of that peptide.  
Positive CD bands of very small intensity at 280 nm have been observed in water and MeOH for 
TFA·H-Tyr-D-Ala-∆ZPhe-Gly-NH2 for which the unordered structure was postulated.37 The 
intensities of the positive ∆EPhe band of E-OMe in MeOH and TFE are about twice as large as 
those observed for TFA·H-Tyr-D-Ala-∆ZPhe-Gly-NH2. It does not allow to exclude the presence of 
some amounts of ordered structures in the conformational equilibria of E-OMe. These structures 
could possibly account for the surprisingly small temperature coefficient of the Phe4 amide proton 
(Table II) which suggests the presence of an intramolecular hydrogen bond.  Still, the NMR and CD 
studies show that an unordered structure is by far the dominating conformation of E-OMe in each 
solvent.  
     At the beginning of the discussion of the results obtained for Z-p-NA, the matter of whether the 
NMR results obtained for the peptide in DMSO may be directly compared with those obtained by 
CD in other solvents should be addressed. The NMR studies on Z-p-NA in DMSO show that there 
are two intramolecular hydrogen bonds in that peptide, formed by the Gly3 and Phe4 amide protons 
(Table II). It indicates that Z-p-NA adopts the folded conformation of the β-turn type. This 
conclusion is confirmed by a large number of non-trivial interatomic contacts detected for Z-p-NA 
from the ROESY spectra (Table IV), especially by contacts NH ∆ZPhe2 ↔ aromatic H’s Phe4, NH 
Gly3 ↔ CαH2 Gly1, CαHα1 Gly3 ↔ NH Gly1, and NH Phe4 ↔ CαH2 Gly1, which suggest the presence 
of a β-turn conformation. Table IV shows that the largest number of contacts was detected for that 
very peptide. At the same time the CD spectrum of Z-p-NA in DMSO shows a very small, negative 
band of the ∆ZPhe residue at 282 nm and a positive band of the p-NA group which is distinctly 
smaller than those observed in other solvents. It suggests that the population of the ordered 
structures of Z-p-NA in DMSO is markedly decreased as compared with MeOH, TFE, and MeCN. 
Still, these ordered structures seem to be of the same type as in the other solvents. Their decreased 
population in DMSO is in some contradiction to the NMR results which indicate an evidently  
ordered conformation of Z-p-NA in DMSO. Since the NMR and CD must reflect the same 
conformation of Z-p-NA in DMSO, then it should be assumed that the CD spectrum of the peptide 
corresponds to its ordered structure seen by the NMR. It is difficult, however, to explain in such a 
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case this substantial decrease of the CD bands of Z-p-NA in DMSO. We can not give at the present 
any reliable explanation for that. One can speculate that the ∆ZPhe side chain of Z-p-NA in DMSO 
adopts such a conformation that its optical activity is strongly diminished or that the peptide is 
present in two conformations with the opposite dispositions of the ∆ZPhe side chain whose CD 
contributions largely cancel each other. Since the CD spectra of Z-p-NA suggest the presence of the 
same ordered structures in each solvent, then it seems reasonable to assume that conclusions drawn 
from the CD spectra of Z-p-NA in MeOH, TFE, and MeCN correspond to the NMR results for Z-p-
NA in DMSO. It was confirmed by the conformational calculations performed for Z-p-NA on the 
basis of NMR results for DMSO and the CD results for MeOH, TFE, and MeCN. As can be seen in 
Fig. 3b, all interatomic contacts detected for Z-p-NA, among them those of significant importance 
for the conformation of the peptide (NH ∆ZPhe2 ↔ aromatic H’s Phe4, NH Gly3 ↔ CαH2 Gly1, 
CαHα1 Gly3 ↔ NH Gly1, and NH Phe4 ↔ CαH2 Gly1), are preserved in the final, lowest-energy 
structure. It proves the correctness of our approach. 
     The CD spectra of Z-p-NA (Fig. 2) in the near-UV in MeOH, TFE, and MeCN show that the 
peptide adopts the type II β-turn conformation at the Gly1 and ∆ZPhe2 residues, stabilized by the 
intramolecular hydrogen bond between the amide proton of Gly3 and the carbonyl oxygen of the 
Boc group.18 The presence of such a conformation is consistent with the NMR studies which show 
that the Gly3 amide proton is involved in a hydrogen bond (Table II) and by the conformational 
calculations (Table V). The analogous reasoning as in the case of Z-OMe indicates that there is 
another β-turn, either at the ∆ZPhe2 and Gly3 or Gly3 and Phe4 residues, stabilized by the 
corresponding 4→1 hydrogen bond. A large intensity of the positive band of the p-NA group 
suggests that this group should be also a part of the second β-turn of Z-p-NA, hence the β-turn at 
the Gly3 and Phe4 residues, with a hydrogen bond between p-NA NH and ∆ZPhe2 CO, seems more 
probable than the one at ∆ZPhe2 and Gly3. It is consistent with the solid state structure of Z-p-NA in 
which two type II β-turns, at Gly1-∆ZPhe2 and Gly3-Phe4, are present.2 Meanwhile the NMR studies 
showed that Z-p-NA adopts the same conformation as Z-OMe. The second intramolecular 
hydrogen bond in Z-p-NA is formed not by the p-NA group, a good hydrogen bond donor, but by 
the Phe4 amide proton (Table II). This result was unexpected since in such a case the p-NA group is 
not a part of any ordered structure. In this connection it is difficult to explain a large intensity of its 
CD band. A distinctly low value of the temperature coefficient of the Phe4 amide proton indicates 
that a hydrogen bond formed by that proton is very strong. The calculations (Table V) showed that 
the second β-turn at the ∆ZPhe2 and Gly3 residues, stabilized by the Phe4 NH···Gly1 CO hydrogen 
bond, is of type III’. The privileged solution conformation of Z-p-NA is presented in Fig. 3b. The 
calculated lowest-energy conformers of that peptide (Fig. 3e) show that its conformational 
flexibility is distinctly reduced as compared with Z-OMe.  
     In the case of E-p-NA, its CD spectra (Fig. 2) in each solvent used are quite similar to each 
other, indicating small solvent-dependence of its conformation. A large intensity of the ∆EPhe and 
especially p-NA CD bands at about 280 and 310 nm, respectively, suggests that, like in the case of 
Z-OMe and Z-p-NA, E-p-NA adopts the conformation composed of two β-turns, stabilized by 
intramolecular hydrogen bonds. One of those β-turns should be located at the Gly3 and Phe4 
residues since otherwise the p-NA group would not be a part of the ordered structure. The positive 
band of the ∆EPhe2 residue indicates that those β-turns may be both of type III or II’, or type 
III/II’.42 The temperature coefficients of the amide protons of E-p-NA (Table II) show the presence 
of two hydrogen bonds formed by NH’s of Phe4 and p-NA. It indicates that there are two 
overlapping β-turns in E-p-NA, located at the ∆EPhe2-Gly3 and Gly3-Phe4 residues. They are 
stabilized by 4→1 hydrogen bonds between Phe4 NH and Gly1 CO and between p-NA NH and 
∆
EPhe2 CO. The calculated lowest-energy conformation of E-p-NA is presented in Fig. 3c. The 
values of dihedral angles of the peptide (Table V) show that its both β-turns are of type III. A very 
large intensity of the negative p-NA band in the CD spectrum of E-p-NA shows that this group is 
much more fixed in that peptide than in Z-p-NA. It is connected to the intramolecular hydrogen 
bond formed by the p-NA group in E-p-NA which is absent in the case of Z-p-NA. A comparable 
intensity of the ∆Phe2 CD bands in the spectra of Z-p-NA and E-p-NA suggests that both peptides 
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are ordered to a similar extent. The ensemble of 50 lowest-energy structures of E-p-NA indicates 
that this peptide is the most rigid of all the peptides studied. Its only part which possesses quite a 
substantial conformational freedom is the Boc group. It agrees very well with this group not being a 
part of the ordered conformation of E-p-NA. 
 
CONCLUSIONS 
     For the first time the conformations of two pairs of dehydropeptides, differing only by the 
configuration of a dehydroamino acid residue, are directly compared. A combined use of the CD 
and NMR methods let determine the detailed solution structures of Z-OMe, E-OMe, Z-p-NA, and 
E-p-NA. It was found that the conformation of Z-OMe is ordered, with two overlapping β-turns, 
whereas the conformation of E-OMe is unordered. It shows that the configuration of the ∆Phe 
residue plays an essential role in the conformational properties of the methyl esters. In the case of p-
nitroanilides, both peptides are ordered to a similar extent but in a different way. The conformation 
of Z-p-NA is the same as that of Z-OMe. A comparison of that conformation with the crystal 
structure of Z-p-NA shows that the peptide preserves only partly its solid state structure in solution.  
In E-p-NA, there are two overlapping β-turns but their position is different than in Z-p-NA. The 
types of β-turns present in Z-OMe, Z-p-NA, and E-p-NA show that the peptides adopt the incipient 
310 helical conformation, left-handed in Z-OMe and Z-p-NA, and right-handed in E-p-NA. It 
follows from the results obtained for Z-p-NA and E-p-NA that in their case the ∆Phe residue 
configuration is important for the kind of ordered structures they adopt but it does not affect the 
extent to which these peptides are ordered. Since the only difference within the two pairs of 
peptides studied is the configuration of a ∆Phe residue, it seems that the conformational differences 
between isomeric peptides result mainly from the different steric interactions between the ∆Phe side 
chain and other parts of the peptides. The results presented show also the influence of the C-
terminal blocking group on a dehydropeptide conformation in relation to the configuration of a 
dehydropeptide. In the case of peptides containing the ∆ZPhe residue, the substitution of the methyl 
group with the p-NA one does not bring about any conformational changes whereas such a 
substitution causes very large conformational changes in dehydropeptides with the ∆EPhe residue. It 
shows that in the latter case a ∆Phe residue of the E configuration alone is not sufficient to induce 
the ordered conformation in a peptide. 
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Legends for Figures 
 
Scheme 1. Structures of Z-OMe, E-OMe, Z-p-NA, and E-p-NA. 
Fig. 1. CD spectra of Z-OMe and E-OMe. 
Fig. 2. CD spectra of Z-p-NA and E-p-NA. 
Fig. 3. The lowest-energy conformers of Z-OMe (a), Z-p-NA.(b), and E-p-NA (c), and ensembles 
of the 50 lowest-energy structures of Z-OMe (d), Z-p-NA.(e), and E-p-NA (f). 
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Table I  Absorption features of Z-OMe, E-OMe,  
Z-p-NA, and E-p-NA in MeOH, in the near-UV  
region  
Peptide λmax [nm] εmax 
 Z-OMea 280 19,500 
E-OMe 280 22,900 
 Z-p-NAa 286 30,500 
E-p-NA 289 30,200 
a
 ref. 17 
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Table II  Temperature coefficients for amide protons of Z-OMe,  
E-OMe, Z-p-NA, and E-p-NA 
dδ/dT (ppm K-1 × 1000) Residue Z-OMea E-OMea Z-p-NAb E-p-NAb 
Gly1 7.2 6.9 5.6 6.4 
∆Phe2 7.4 7.2 4.8 5.5 
Gly3  5.2* 8.1  3.0* 6.6 
Phe4  5.4* 4.7  0.7*  3.5* 
p-NA – – 5.6  2.6* 
*
 protons forming hydrogen bonds 
a
 in CDCl3  
b
 in DMSO-d6 
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Table III  Dependence of amide protons chemical shifts  
on the solvent polarity for Z-OMe and E-OMe  
∆δ = δNH(DMSO-d6) - δNH(CDCl3) Residue Z-OMe E-OMe 
Gly1 1.47 1.61 
∆Phe2 1.53 1.30 
Gly3  0.72* 2.24 
Phe4  0.80* 1.22 
*
 protons forming hydrogen bonds 
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Table IV  Interatomic non-trivial contacts in Z-OMe, Z-p-NA, and E-p-NA detected 
from the ROESY spectra 
Interatomic contacts in: 
Z-OMea Z-p-NAb E-p-NAb 
CαH2 Gly1 ↔ NH ∆ZPhe2 NH ∆ZPhe2 ↔ CαH2 Gly1  NH ∆EPhe2 ↔ CαHα1 Gly1  
CαH2 Gly1 ↔ NH Gly3 NH ∆ZPhe2 ↔ NH Gly1  NH ∆EPhe2 ↔ CαHα2 Gly1  
NH ∆ZPhe2 ↔ NH Gly3 NH ∆ZPhe2 ↔ NH Gly3  NH ∆EPhe2 ↔ NH Gly3  
NH Gly3 ↔ NH Phe4 NH ∆ZPhe2 ↔ aromatic H’s Phe4 NH Gly3 ↔ NH Phe4  
CαH2 Gly3 ↔ NH Phe4 NH Gly3 ↔ CαH2 Gly1  aromatic H’s Phe4 ↔ CβH ∆EPhe2 
 NH Gly3 ↔ CβH ∆ZPhe2  NH p-NA ↔ CβH ∆EPhe2  
 NH Gly3 ↔ NH Phe4  NH p-NA ↔ CαH Phe4  
 CαHα1 Gly3 ↔ NH Gly1  NH p-NA ↔ NH Phe4  
 NH Phe4 ↔ CαH2 Gly1   
 NH Phe4 ↔ CαHα2 Gly3   
 NH p-NA ↔ CαH Phe4   
 NH p-NA ↔ NH Phe4   
a
 in CDCl3  
b
 in DMSO-d6 
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Table V  Torsion angles values of Z-OMe, Z-p-NA, and E-p-NA calculated on the basis 
of NMR and CD parameters with an X-PLOR program. Standard deviations for 50 
lowest-energy structures are given in brackets 
Z-OMe Z-p-NA E-p-NA Residue 
φ ψ φ ψ φ ψ 
Gly1 -48° (±6°) 114° (±25°) -56° (±2°) 114° (±5°) 143° (±89°) -116° (±101°) 
∆Phe2 49° (±11°) 18° (±21°) 30° (±2°) 30° (±2°) -26° (±3°) -34° (±2°) 
Gly3 77° (±36°) 10° (±34°) 39° (±4°) 53° (±11°) -54° (±3°) -7° (±3°) 
Phe4 -41° (±87°) – -61° (±12°) 27° (±90°) -65° (±4°) -40° (±3°) 
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Scheme 1  Structures of Z-OMe, E-OMe, Z-p-NA, and E-p-NA.  
126x180mm (600 x 600 DPI)  
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Figure 1  CD spectra of Z-OMe.  
139x99mm (300 x 300 DPI)  
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Figure 2  CD spectra of Z-p-NA and E-p-NA.  
150x106mm (300 x 300 DPI)  
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Figure 3  The lowest-energy conformers of Z-OMe (a), Z-p-NA (b), and E-p-NA (c), and ensembles 
of the 50 lowest-energy structures of Z-OMe (d), b>Z-p-NA (e), and E-p-NA (f).  
254x190mm (96 x 96 DPI)  
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